A.G. Tabák, C. Herder, W. Rathmann, E.J. Brunner, M. Kivimäki, Prediabetes: a high-risk state for diabetes development. Lancet 379, 2279–2290 (2012)
Article PubMed PubMed Central Google Scholar
K. Færch, D. Vistisen, N.B. Johansen, M.E. Jørgensen, Cardiovascular risk stratification and management in pre-diabetes. Curr. Diab Rep. 14, 493 (2014)
American Diabetes Association, Standards of medical care in diabetes. Diabetes Care 43, S1–S224 (2020)
J.B. Sussman, D.M. Kent, J.P. Nelson, R.A. Hayward, Improving diabetes prevention with benefit based tailored treatment: Risk based reanalysis of diabetes prevention program. BMJ 350, 1–10. (2015)
W.K. Chung, K. Erion, J.C. Florez, A.T. Hattersley, M.F. Hivert et al. Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 43, 1617–1635 (2020)
Article CAS PubMed PubMed Central Google Scholar
D.P. Martono, R. Lub, H.J. Lambers Heerspink, E. Hak, B. Wilffert et al. Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review. Diabet. Med. 32, 853–864 (2015)
Article CAS PubMed Google Scholar
M. Pikkemaat, O. Melander, P. Hjerpe, K. Bengtsson Boström, Prediction of treatment response in patients with newly diagnosed type 2 diabetes: the Skaraborg diabetes register. J. Diabetes Complic. 31, 854–858 (2017)
J.M. Dennis, B.M. Shields, W.E. Henley, A.G. Jones, A.T. Hattersley, Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol. 7, 442–451 (2019)
Article PubMed PubMed Central Google Scholar
J.M. Dennis, W.E. Henley, M.N. Weedon, M. Lonergan, L.R. Rodgers et al. Sex and BMI alter the benefits and risks of sulfonylureas and thiazolidinediones in type 2 diabetes: a framework for evaluating stratification using routine clinical and individual trial data. Diabetes Care 41, 1844–1853 (2018)
American Diabetes Association, Classification and diagnosis of diabetes. Diabetes Care 40, S11–S24 (2017)
D.M. Nathan, B. Balkau, E. Bonora, K. Borch-Johnsen, J.B. Buse et al. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32, 1327–1334 (2009)
American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1), S62–S69 (2010)
Article PubMed Central Google Scholar
S. Rodríguez-Segade, J. Rodríguez, J.M. García Lopez, F.F. Casanueva, F. Camiña, Estimation of the glycation gap in diabetic patients with stable glycemic control. Diabetes Care 35, 2447–2450 (2012)
Article PubMed PubMed Central Google Scholar
L. Campbell, T. Pepper, K. Shipman, HbA1c: a review of non-glycaemic variables. J. Clin. Pathol. 72, 12–19 (2019)
Article CAS PubMed Google Scholar
K. Færch, M. Alssema, D.J. Mela, R. Borg, D. Vistisen, Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA 1c in individuals with and without diabetes. Nutr. Diabetes 8, 38 (2018)
Article PubMed PubMed Central Google Scholar
J. Blum, S. Aeschbacher, T. Schoen, M. Bossard, K. Pumpol et al. Prevalence of prediabetes according to hemoglobin A1c versus fasting plasma glucose criteria in healthy adults. Acta Diabetol. 52, 631–632 (2015)
Y. Xu, L. Wang, J. He, Y. Bi, M. Li et al. Prevalence and control of diabetes in Chinese adults. JAMA J. Am. Med. Assoc. 310, 948–958 (2013)
C.M.Y. Lee, S. Colagiuri, M. Woodward, E.W. Gregg, R. Adams et al. Comparing different definitions of prediabetes with subsequent risk of diabetes: An individual participant data meta-analysis involving 76 513 individuals and 8208 cases of incident diabetes. BMJ Open Diabetes Res. Care 7, 1–10 (2019)
B. Richter, B. Hemmingsen, M.I. Metzendorf, Y. Takwoingi Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia. Cochrane Database Syst. Rev. 10, CD012661 (2018)
C.S. Mogensen, K. Færch, L. Bruhn, H. Amadid, I. Tetens et al. Timing and frequency of daily energy intake in adults with prediabetes and overweight or obesity and their associations with body fat. Nutrients 12, 3494 (2020).
K. Færch, H. Amadid, L.B. Nielsen, M. Ried-Larsen, K. Karstoft, et al. Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial). BMJ Open 7 e013802 (2017) .
K. Færch, M.B. Blond, L. Bruhn, H. Amadid, D. Vistisen et al. The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial. Diabetologia 64, 42–55 (2021)
K.K.B. Clemmensen, M.B. Blond, H. Amadid, L. Bruhn, D. Vistisen et al. No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: a post hoc analysis from the randomized controlled PRE-D trial. Diabetes Obes. Metab. 23, 530–539 (2021)
Article CAS PubMed Google Scholar
Ministry of Environment and Food of Denmark, The Danish official dietary recommendations (Ministry of Environment and Food of Denmark, Glostrup, Denmark, 2013)
C.F. Dormann, J. Elith, S. Bacher, C. Buchmann, G. Carl et al. Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography 36, 27–46 (2013)
S. Sumitani, S. Morita, Y. Utsu, K. Mukai, S. Miki et al. Effectiveness of metformin and lifestyle interventions as an initial treatment in japanese patients with newly diagnosed type 2 diabetes: a prospective observational study. J. Med. Investig. 59, 166–173 (2012)
R.M. Bergenstal, R.L. Gal, C.G. Connor, R. Gubitosi-Klug, D. Kruger et al. Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels. Ann. Intern. Med. 167, 95–102 (2017)
J.S. Yudkin, R.D. Forrest, C.A. Jackson, A.J. Ryle, S. Davie et al. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 33, 208–215 (1990)
留言 (0)